COVID-19: berrikuspenen arteko aldeak
Ezabatutako edukia Gehitutako edukia
No edit summary |
No edit summary |
||
206. lerroa:
Egun existitzen diren [[Antibiriko|antibiralek]] gaixotasun hau sendatzeko balio dezaketen aztertzen dihardute zientzialariek;<ref name=":1" /> horien artean [[indinavir]], [[saquinavir]], [[remdesivir]], [[lopinavir]]/[[ritonavir]] eta [[Interferoi|beta interferoia]] proteasa inhibitzaileak proposatu dira.<ref>{{Erreferentzia|izena=Zhijian|abizena=Xu|izenburua=Nelfinavir was predicted to be a potential inhibitor of 2019 nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation|orrialdeak=2020.01.27.921627|hizkuntza=en|abizena2=Peng|abizena3=Shi|abizena4=Zhu|abizena5=Mu|abizena6=Wang|abizena7=Zhu|izena2=Cheng|izena3=Yulong|izena4=Zhengdan|izena5=Kaijie|izena6=Xiaoyu|izena7=Weiliang|data=2020-01-28|url=https://www.biorxiv.org/content/10.1101/2020.01.27.921627v1|aldizkaria=bioRxiv|doi=10.1101/2020.01.27.921627|sartze-data=2020-01-29}}</ref><ref>Paules, Catharine I.; Marston, Hilary D.; Fauci, Anthony S. (2020ko urtarrilaren 23). "Coronavirus Infections—More Than Just the Common Cold". ''JAMA''. doi:10.1001/jama.2020.0757. <nowiki>PMID 31971553</nowiki>.</ref><ref>{{Erreferentzia|izenburua=Gilead assessing Ebola drug as possible coronavirus treatment|hizkuntza=en|data=2020-01-23|url=https://www.reuters.com/article/gilead-coronavirus-idUSL4N29S45D|aldizkaria=Reuters|sartze-data=2020-01-29}}</ref> Aurrez aipatutako [[antigorputz monoklonal]]en (mAbs) eraginkortasuna ere ikerketapean dago.<ref>{{Erreferentzia|izenburua=Coronavirus: Vir Biotechnology and Novavax announce vaccine plans|hizkuntza=en-GB|url=https://www.pharmaceutical-technology.com/news/coronavirus-vir-biotechnology-novavax-vaccine/|sartze-data=2020-01-29}}</ref>
[[Klorokina]]ren fosfatoa itxurazko hobekuntza eragin du birusak sortzen duen pneumoniaren tratamenduan <ref> Gao, Jianjun; Tian, Zhenxue; Yang, Xu (2020-02-19) [https://www.jstage.jst.go.jp/article/bst/advpub/0/advpub_2020.01047/_article Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies] BioScience Trends </ref> <ref> Sebastian, N. (2020-02-27) [http://web.archive.org/web/20200229075003/https://gacetamedica.com/investigacion/covid-19-el-fosfato-de-cloroquina-podria-tratar-la-neumonia/ Covid-19: El fosfato de cloroquina podría tratar la neumonía] Gaceta Médica </ref>. Beste deribatu batek, [[hidroxiklorokina]]k, "zitokinen ekaitza" kaltegarria, antza, ekiditen du <ref> Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. (March 2020). "A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19". The New England Journal of Medicine </ref>. Efektu bera du [[tozilizumab]] izeneko botikak ere <ref> [https://web.archive.org/web/20200314152506/https://www.ilmessaggero.it/italia/coronavirus_farmaco_artrite_ultime_notizie_news_napoli-5109045.html Coronavirus, via libera dell'Aifa al farmaco anti-artrite efficace su 3 pazienti e a un antivirale: test in 5 centri] Il Messagero, 2020-03-13an </ref>
[[Seroterapia]]ren erabilera ere ikerketapean dago, hots, gaitza gainditu dutenen odolaren transfusioa. Odol honek birusaren aurkako [[antigorputz]]ak ditu <ref> [https://www.vox.com/2020/3/12/21176783/coronavirus-covid-19-deaths-china-treatment-cytokine-storm-syndrome How doctors can potentially significantly reduce the number of deaths from Covid-19] 2020ko martxoaren 12an </ref>
| |||